{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:55:09Z","timestamp":1790117709391,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-83840-3","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T21:10:49Z","timestamp":1736802649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The burden of prostate cancer in the North Africa and Middle East Region from 1990 to 2021"],"prefix":"10.1038","volume":"15","author":[{"given":"Saeid","family":"Safiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Shamekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamaleddin","family":"Hassanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asra","family":"Fazlollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J. M.","family":"Sullman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mortaza","family":"Raeisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali-Asghar","family":"Kolahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"issue":"9361","key":"83840_CR1","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(03)12779-1","volume":"361","author":"AM DeMarzo","year":"2003","unstructured":"DeMarzo, A. M., Nelson, W. G., Isaacs, W. B. & Epstein, J. I. Pathological and molecular aspects of prostate cancer. Lancet 361 (9361), 955\u2013964 (2003).","journal-title":"Lancet"},{"issue":"24","key":"83840_CR2","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/jama.2017.7248","volume":"317","author":"MS Litwin","year":"2017","unstructured":"Litwin, M. S. & Tan, H-J. The diagnosis and treatment of prostate Cancer: A review. JAMA 317 (24), 2532\u20132542 (2017).","journal-title":"JAMA"},{"issue":"17","key":"83840_CR3","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.3390\/molecules27175730","volume":"27","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha, M. et al. Prostate Cancer Review: Genetics, diagnosis, treatment options, and alternative approaches. Molecules 27 (17), 5730 (2022).","journal-title":"Molecules"},{"key":"83840_CR4","doi-asserted-by":"crossref","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J. Clin. 71(3), 209\u20139. (2021).","DOI":"10.3322\/caac.21660"},{"issue":"3","key":"83840_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s44197-023-00103-6","volume":"13","author":"W Zhang","year":"2023","unstructured":"Zhang, W. et al. Global burden of prostate cancer and association with socioeconomic status, 1990\u20132019: A systematic analysis from the global burden of disease study. J. Epidemiol. Global Health. 13 (3), 407\u2013421 (2023).","journal-title":"J. Epidemiol. Global Health"},{"issue":"1","key":"83840_CR6","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.2217\/fon-2019-0639","volume":"16","author":"G Gustavsen","year":"2019","unstructured":"Gustavsen, G., Gullet, L., Cole, D., Lewine, N. & Bishoff, J. T. Economic burden of illness associated with localized prostate cancer in the United States. Future Oncol. 16 (1), 4265\u20134277 (2019).","journal-title":"Future Oncol."},{"issue":"2","key":"83840_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren, O. et al. 2022 update on prostate Cancer epidemiology and risk Factors\u2014A systematic review. Eur. Urol. 84 (2), 191\u2013206 (2023).","journal-title":"Eur. Urol."},{"issue":"3","key":"83840_CR8","first-page":"28","volume":"8","author":"A Barsouk","year":"2020","unstructured":"Barsouk, A. et al. Epidemiology, staging and management of prostate Cancer. Med. Sci. 8 (3), 28 (2020).","journal-title":"Med. Sci."},{"issue":"3","key":"83840_CR9","doi-asserted-by":"publisher","first-page":"e1004362","DOI":"10.1371\/journal.pmed.1004362","volume":"21","author":"H Cui","year":"2024","unstructured":"Cui, H. et al. Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses. PLoS Med. 21 (3), e1004362 (2024).","journal-title":"PLoS Med."},{"issue":"2","key":"83840_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.eururo.2021.04.013","volume":"80","author":"BF Darst","year":"2021","unstructured":"Darst, B. F. et al. Combined effect of a polygenic risk score and rare genetic variants on prostate Cancer risk. Eur. Urol. 80 (2), 134\u2013138 (2021).","journal-title":"Eur. Urol."},{"key":"83840_CR11","doi-asserted-by":"crossref","unstructured":"Trapani, D., Siqueira, M., Sengar, M. & Lombe, D. C. Prostate cancer: Burden, Epidemiology and Priority Interventions, p. 112\u2013117 (Routledge, 2023).","DOI":"10.4324\/9781003306689-17"},{"key":"83840_CR12","doi-asserted-by":"crossref","unstructured":"Abbasi-Kangevari, M. et al. The burden of prostate cancer in North Africa and Middle East, 1990\u20132019: Findings from the global burden of disease study. Front. Oncol. ;12. (2022).","DOI":"10.3389\/fonc.2022.961086"},{"issue":"2","key":"83840_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/pros.24258","volume":"82","author":"L-S Luo","year":"2022","unstructured":"Luo, L-S. et al. Spatial and temporal patterns of prostate cancer burden and their association with Socio-Demographic Index in Asia, 1990\u20132019. Prostate 82 (2), 193\u2013202 (2022).","journal-title":"Prostate"},{"issue":"23","key":"83840_CR14","doi-asserted-by":"publisher","first-page":"21419","DOI":"10.1002\/cam4.6689","volume":"12","author":"G Kearney","year":"2023","unstructured":"Kearney, G. et al. Burden of prostate cancer in the Middle East: A comparative analysis based on global cancer observatory data. Cancer Med. 12 (23), 21419\u201321425 (2023).","journal-title":"Cancer Med."},{"key":"83840_CR15","unstructured":"Schumacher, A. E., Kyu, H. H., Aali, A., Abbafati, C., Abbas, J. & Abbasgholizadeh, R., et al. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950\u20132021, and the impact of the COVID-19 pandemic: A comprehensive demographic analysis for the Global Burden of Disease Study 2021. The Lancet. 2024;403(10440), 1989\u20132056."},{"issue":"10440","key":"83840_CR16","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"Global incidence","year":"2024","unstructured":"Global incidence. Prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: A systematic analysis for the global burden of Disease Study 2021. Lancet 403 (10440), 2133\u20132161 (2024).","journal-title":"Lancet"},{"key":"83840_CR17","doi-asserted-by":"publisher","first-page":"961086","DOI":"10.3389\/fonc.2022.961086","volume":"12","author":"M Abbasi-Kangevari","year":"2022","unstructured":"Abbasi-Kangevari, M. et al. The burden of prostate cancer in North Africa and Middle East, 1990\u20132019: Findings from the global burden of disease study. Front. Oncol. 12, 961086 (2022).","journal-title":"Front. Oncol."},{"key":"83840_CR18","doi-asserted-by":"crossref","unstructured":"Sayan, M. et al. Prostate Cancer awareness in the Middle East: A cross-sectional International Study. JCO Global Oncol. (10), e2400171. (2024).","DOI":"10.1200\/GO.24.00171"},{"key":"83840_CR19","doi-asserted-by":"crossref","unstructured":"He, M. et al. Unleashing novel horizons in advanced prostate cancer treatment: investigating the potential of prostate specific membrane antigen-targeted nanomedicine-based combination therapy. Front. Immunol.  14. (2023).","DOI":"10.3389\/fimmu.2023.1265751"},{"issue":"7","key":"83840_CR20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1159\/000513258","volume":"99","author":"V Achard","year":"2021","unstructured":"Achard, V., Panje, C. M., Engeler, D., Zilli, T. & Putora, P. M. Localized and locally advanced prostate Cancer: Treat. Opt. Oncology 99 (7), 413\u2013421 (2021).","journal-title":"Oncology"},{"issue":"8","key":"83840_CR21","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.trecan.2020.04.010","volume":"6","author":"U Swami","year":"2020","unstructured":"Swami, U., McFarland, T. R., Nussenzveig, R. & Agarwal, N. Advanced prostate Cancer: Treatment advances and future directions. Trends Cancer. 6 (8), 702\u2013715 (2020).","journal-title":"Trends Cancer"},{"key":"83840_CR22","doi-asserted-by":"crossref","unstructured":"Al-Hussaini, M., Al-Ani, A., Hammouri, M., Al-Huneidy, L. & Mansour, A. Investigating the impact of COVID-19 on patients with cancer from areas of conflict within the MENA region treated at King Hussein Cancer Center. Front. Oncol. , 13. (2023).","DOI":"10.3389\/fonc.2023.1088000"},{"issue":"1","key":"83840_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12894-024-01427-6","volume":"24","author":"M Sayan","year":"2024","unstructured":"Sayan, M. et al. Prostate cancer presentation and management in the Middle East. BMC Urol. 24 (1), 35 (2024).","journal-title":"BMC Urol."},{"issue":"2","key":"83840_CR24","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/bju.15699","volume":"130","author":"J Nossiter","year":"2022","unstructured":"Nossiter, J. et al. Impact of the COVID-19 pandemic on the diagnosis and treatment of men with prostate cancer. BJU Int. 130 (2), 262\u2013270 (2022).","journal-title":"BJU Int."},{"key":"83840_CR25","doi-asserted-by":"crossref","unstructured":"Wang H, Paulson KR, Pease SA, Watson S, Comfort H, Zheng P, et al. Estimating excess mortality due to the COVID-19 pandemic: A systematic analysis of COVID-19-related mortality, 2020\u201321. The Lancet. 399(10334), 1513-36 (2022).","DOI":"10.1016\/S0140-6736(21)02796-3"},{"issue":"1","key":"83840_CR26","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1186\/s12913-022-08526-w","volume":"22","author":"G Bj\u00f8rnelv","year":"2022","unstructured":"Bj\u00f8rnelv, G., Hagen, T. P., Forma, L. & Aas, E. Care pathways at end-of-life for cancer decedents: Registry based analyses of the living situation, healthcare utilization and costs for all cancer decedents in Norway in 2009\u20132013 during their last 6 months of life. BMC Health Serv. Res. 22 (1), 1221 (2022).","journal-title":"BMC Health Serv. Res."},{"issue":"3","key":"83840_CR27","doi-asserted-by":"publisher","first-page":"583","DOI":"10.31557\/APJCP.2020.21.3.583","volume":"21","author":"AMA Nasser","year":"2020","unstructured":"Nasser, A. M. A., Geng, Y. & Al-Wesabi, S. A. The prevalence of smoking (cigarette and waterpipe) among University students in some Arab countries: A systematic review. Asian Pac. J. cancer Prevent. APJCP. 21 (3), 583\u2013591 (2020).","journal-title":"Asian Pac. J. cancer Prevention: APJCP"},{"key":"83840_CR28","doi-asserted-by":"crossref","unstructured":"Alanazi, A. M. et al. The associations between cigarette smoking behavior and the use of heated tobacco products among Arab cigarette smokers: Findings from Saudi Arabia, Egypt, Kuwait, and Yemen. Journal of Ethnicity in Substance Abuse 1\u201314.","DOI":"10.1080\/15332640.2023.2204075"},{"key":"83840_CR29","doi-asserted-by":"crossref","unstructured":"Nikoloski, Z. Obesity in Middle East. Metabolic Syndrome: A Comprehensive Textbook, p. 65\u201380 (Springer, 2024).","DOI":"10.1007\/978-3-031-40116-9_6"},{"issue":"8","key":"83840_CR30","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1002\/cncr.32702","volume":"126","author":"M-P Huynh-Le","year":"2020","unstructured":"Huynh-Le, M-P. et al. Age dependence of modern clinical risk groups for localized prostate cancer\u2014A population-based study. Cancer 126 (8), 1691\u20131699 (2020).","journal-title":"Cancer"},{"issue":"1","key":"83840_CR31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1177\/00207314221129052","volume":"53","author":"AAB Wirayuda","year":"2023","unstructured":"Wirayuda, A. A. B., Al-Mahrezi, A. & Chan, M. F. Factors impacting life expectancy in Bahrain: Evidence from 1971 to 2020 data. Int. J. Soc. Determinants Health Health Serv. 53 (1), 74\u201384 (2023).","journal-title":"Int. J. Social Determinants Health Health Serv."},{"key":"83840_CR32","doi-asserted-by":"crossref","unstructured":"Wirayuda, A. A. B. et al. Unlocking the secrets of longevity: Exploring the impact of socioeconomic factors and health resources on life expectancy in Oman and Qatar. INQUIRY J. Health Care Organ. Provis. Financ. 60, 00469580231212224. (2023).","DOI":"10.1177\/00469580231212224"},{"issue":"1","key":"83840_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12889-022-14720-6","volume":"23","author":"MA Hameed","year":"2023","unstructured":"Hameed, M. A., Rahman, M. M. & Khanam, R. The health consequences of civil wars: Evidence from Afghanistan. BMC Public. Health. 23 (1), 154 (2023).","journal-title":"BMC Public. Health"},{"key":"83840_CR34","doi-asserted-by":"crossref","unstructured":"Balkhi, B., Alshayban, D. & Alotaibi, N. M. Impact of healthcare expenditures on healthcare outcomes in the Middle East and North Africa (MENA) region: A cross-country comparison, 1995\u20132015. Front. Public. Health 8. (2021).","DOI":"10.3389\/fpubh.2020.624962"},{"key":"83840_CR35","unstructured":"Jain, M. A., Leslie, S. W. & Sapra, A. Prostate cancer Screening (StatPearls Publishing, 2023)."},{"key":"83840_CR36","doi-asserted-by":"crossref","unstructured":"Ilic, D., Neuberger, M. M., Djulbegovic, M. & Dahm, P. Screening for prostate cancer. Cochrane Database Syst. Rev. (1). (2013).","DOI":"10.1002\/14651858.CD004720.pub3"},{"key":"83840_CR37","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3389\/fonc.2020.00582","volume":"10","author":"K Ried","year":"2020","unstructured":"Ried, K., Tamanna, T., Matthews, S., Eng, P. & Sali, A. New screening test improves detection of prostate cancer using circulating tumor cells and prostate-specific markers. Front. Oncol. 10, 582 (2020).","journal-title":"Front. Oncol."},{"issue":"12","key":"83840_CR38","doi-asserted-by":"publisher","first-page":"e2031349","DOI":"10.1001\/jamanetworkopen.2020.31349","volume":"3","author":"SL Washington","year":"2020","unstructured":"Washington, S. L. et al. Regional variation in active surveillance for low-risk prostate cancer in the US. JAMA Netw. open. 3 (12), e2031349\u2013e (2020).","journal-title":"JAMA Netw. open."},{"issue":"2","key":"83840_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet, N. et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142020 update. Part 1: Screening, diagnosis, and local treatment with curative intent. Eur. Urol. 79 (2), 243\u2013262 (2021).","journal-title":"Eur. Urol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83840-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83840-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83840-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T21:10:56Z","timestamp":1736802656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83840-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["83840"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-83840-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]},"assertion":[{"value":"13 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The present study was reviewed and approved by Ethics Committee of Shahid Beheshti University of Medical Sciences, Tehran, Iran (Ethics code: IR.SBMU.RETECH.REC.1402.046). All methods were performed in accordance with the national guidelines and regulations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study is based on publicly available data and solely reflects the opinions of its authors and not that of the Institute for Health Metrics and Evaluation.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author note"}}],"article-number":"1853"}}